The Central and Eastern European (CEE) region should stand out as a highly attractive location for clinical research compared to many surrounding regions.
But what makes it so attractive❓
✅ Recruitment potential due to the lower rate of studies
➡️ Less saturation and reduced competition for participants
➡️ Greater investigator enthusiasm
➡️ Higher availability of eligible patients
✅ Quality
➡️ High regulatory and GCP compliance
➡️ Centralized healthcare system with strong operational discipline and oversight
➡️ Approximately 60 % of inspections resulted in a “No Action Indicated” (NAI)
✅ Price
➡️ Monitoring hourly fees are on average 60% of US cost
➡️ Investigator and hospital fees are the lowest in the EU
➡️ Avarage regulatory costs are significantly lower then in other EU regions
This leads directly to:
⚡ Faster enrollment and trial timelines
📈 Enhanced quality
💰 Reduced overall costs
At BiTrial, we’ve seen firsthand how the advantages of the CEE region translate into successful studies for our partners.
👉 Unlock the potential of the CEE region! Contact us for a free consultation and let’s design your next clinical trial together!
⏐CRO BULGARIA⏐CRO BOSNIA AND HERZEGOVINA⏐CRO CROATIA⏐CRO CZECH REPUBLIC⏐CRO HUNGARY⏐CRO MACEDONIA⏐CRO MONTENEGRO⏐CRO MOLDOVA⏐CRO POLAND⏐CRO ROMANIA⏐CRO SLOVAKIA ⏐CRO SERBIA⏐CRO SLOVENIA⏐